ACADIA Pharmaceuticals, Inc. (ACAD) Announces Multiple Presentations of Data from Phase III Pimavanserin Program at the 17th International Congress of Parkinson’s Disease and Movement Disorders
6/18/2013 9:25:51 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the Jefferies and Co. Global Healthcare Conference on June 5, 2013
5/29/2013 8:00:22 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock
5/21/2013 11:38:50 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Added to NASDAQ Biotechnology Index
5/20/2013 10:22:00 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Proposed Public Offering of Common Stock
5/15/2013 10:33:33 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Prices Public Offering of Common Stock
5/15/2013 9:53:53 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Reports First Quarter 2013 Financial Results
5/8/2013 7:46:45 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Announce First Quarter 2013 Financial Results on May 7, 2013
4/30/2013 7:09:19 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013
4/25/2013 9:04:14 AM
More...
|
FDA Asks ACADIA Pharmaceuticals, Inc. (ACAD) to Skip Late Stage Study and File NDA After Successful Results
4/11/2013 7:35:28 AM
More...
|
|